High-dose-rate brachytherapy using molds for lip and oral cavity tumors

Teruhisa Unetsubo, Hidenobu Matsuzaki, Mitsuhiro Takemoto, Kuniaki Katsui, Marina Hara, Norihisa Katayama, Takahiro Waki, Susumu Kanazawa, Jun-Ichi Asaumi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: High-dose-rate (HDR) brachytherapy using the mold technique is a less invasive treatment for early lip and oral cavity cancer. However, limited reports exist regarding the feasibility of this method. In this retrospective study, we evaluated the outcome of this therapy and investigated its feasibility for lip and oral cavity tumors. Methods: Between May 2002 and December 2010, 17 patients (median age, 80.0years) with histologically confirmed squamous cell carcinoma of the lip or oral cavity were treated by means of HDR brachytherapy using the mold technique after external beam radiotherapy (EBRT). Tumor sites included the buccal mucosa in eight cases, the gingiva in three cases, the lips in two cases, the floor of the mouth in two cases, and the hard palate in two cases. For all patients, EBRT (30Gy/15 fractions), was performed before HDR brachytherapy. Two 6-Gy fractions were delivered twice daily for 2days a week with an interval of 6hours between the fractions. The total HDR brachytherapy dose was 24Gy. Prior to EBRT, two patients with neck metastasis underwent neck dissection, and one patient with an exophytic tumor underwent tumor resection. Results: The median follow-up period was 53.4 (range, 4.8-83.4) months. Of the 17 patients, 14 (82.4%) achieved a complete response, and three (17.6%) displayed a partial response. Conclusions: Although there is a need to improve the technical aspects of the treatment protocol, HDR brachytherapy using the mold technique might be a therapeutic option for superficial lip or oral cavity tumors, especially in older patients who have a poor performance status or are in poor physical condition.

Original languageEnglish
Article number81
JournalRadiation Oncology
Volume10
Issue number1
DOIs
Publication statusPublished - Apr 8 2015

Fingerprint

Brachytherapy
Lip
Mouth
Fungi
Neoplasms
Radiotherapy
Hard Palate
Mouth Floor
Neck Dissection
Mouth Neoplasms
Mouth Mucosa
Gingiva
Clinical Protocols
Squamous Cell Carcinoma
Neck
Therapeutics
Retrospective Studies
Neoplasm Metastasis

Keywords

  • Brachytherapy
  • High-dose-rate
  • Lip cancer
  • Mold
  • Oral cavity cancer

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

High-dose-rate brachytherapy using molds for lip and oral cavity tumors. / Unetsubo, Teruhisa; Matsuzaki, Hidenobu; Takemoto, Mitsuhiro; Katsui, Kuniaki; Hara, Marina; Katayama, Norihisa; Waki, Takahiro; Kanazawa, Susumu; Asaumi, Jun-Ichi.

In: Radiation Oncology, Vol. 10, No. 1, 81, 08.04.2015.

Research output: Contribution to journalArticle

@article{a11c976a45af4ab2ae3f1f4fc1163fa3,
title = "High-dose-rate brachytherapy using molds for lip and oral cavity tumors",
abstract = "Background: High-dose-rate (HDR) brachytherapy using the mold technique is a less invasive treatment for early lip and oral cavity cancer. However, limited reports exist regarding the feasibility of this method. In this retrospective study, we evaluated the outcome of this therapy and investigated its feasibility for lip and oral cavity tumors. Methods: Between May 2002 and December 2010, 17 patients (median age, 80.0years) with histologically confirmed squamous cell carcinoma of the lip or oral cavity were treated by means of HDR brachytherapy using the mold technique after external beam radiotherapy (EBRT). Tumor sites included the buccal mucosa in eight cases, the gingiva in three cases, the lips in two cases, the floor of the mouth in two cases, and the hard palate in two cases. For all patients, EBRT (30Gy/15 fractions), was performed before HDR brachytherapy. Two 6-Gy fractions were delivered twice daily for 2days a week with an interval of 6hours between the fractions. The total HDR brachytherapy dose was 24Gy. Prior to EBRT, two patients with neck metastasis underwent neck dissection, and one patient with an exophytic tumor underwent tumor resection. Results: The median follow-up period was 53.4 (range, 4.8-83.4) months. Of the 17 patients, 14 (82.4{\%}) achieved a complete response, and three (17.6{\%}) displayed a partial response. Conclusions: Although there is a need to improve the technical aspects of the treatment protocol, HDR brachytherapy using the mold technique might be a therapeutic option for superficial lip or oral cavity tumors, especially in older patients who have a poor performance status or are in poor physical condition.",
keywords = "Brachytherapy, High-dose-rate, Lip cancer, Mold, Oral cavity cancer",
author = "Teruhisa Unetsubo and Hidenobu Matsuzaki and Mitsuhiro Takemoto and Kuniaki Katsui and Marina Hara and Norihisa Katayama and Takahiro Waki and Susumu Kanazawa and Jun-Ichi Asaumi",
year = "2015",
month = "4",
day = "8",
doi = "10.1186/s13014-015-0390-z",
language = "English",
volume = "10",
journal = "Radiation Oncology",
issn = "1748-717X",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - High-dose-rate brachytherapy using molds for lip and oral cavity tumors

AU - Unetsubo, Teruhisa

AU - Matsuzaki, Hidenobu

AU - Takemoto, Mitsuhiro

AU - Katsui, Kuniaki

AU - Hara, Marina

AU - Katayama, Norihisa

AU - Waki, Takahiro

AU - Kanazawa, Susumu

AU - Asaumi, Jun-Ichi

PY - 2015/4/8

Y1 - 2015/4/8

N2 - Background: High-dose-rate (HDR) brachytherapy using the mold technique is a less invasive treatment for early lip and oral cavity cancer. However, limited reports exist regarding the feasibility of this method. In this retrospective study, we evaluated the outcome of this therapy and investigated its feasibility for lip and oral cavity tumors. Methods: Between May 2002 and December 2010, 17 patients (median age, 80.0years) with histologically confirmed squamous cell carcinoma of the lip or oral cavity were treated by means of HDR brachytherapy using the mold technique after external beam radiotherapy (EBRT). Tumor sites included the buccal mucosa in eight cases, the gingiva in three cases, the lips in two cases, the floor of the mouth in two cases, and the hard palate in two cases. For all patients, EBRT (30Gy/15 fractions), was performed before HDR brachytherapy. Two 6-Gy fractions were delivered twice daily for 2days a week with an interval of 6hours between the fractions. The total HDR brachytherapy dose was 24Gy. Prior to EBRT, two patients with neck metastasis underwent neck dissection, and one patient with an exophytic tumor underwent tumor resection. Results: The median follow-up period was 53.4 (range, 4.8-83.4) months. Of the 17 patients, 14 (82.4%) achieved a complete response, and three (17.6%) displayed a partial response. Conclusions: Although there is a need to improve the technical aspects of the treatment protocol, HDR brachytherapy using the mold technique might be a therapeutic option for superficial lip or oral cavity tumors, especially in older patients who have a poor performance status or are in poor physical condition.

AB - Background: High-dose-rate (HDR) brachytherapy using the mold technique is a less invasive treatment for early lip and oral cavity cancer. However, limited reports exist regarding the feasibility of this method. In this retrospective study, we evaluated the outcome of this therapy and investigated its feasibility for lip and oral cavity tumors. Methods: Between May 2002 and December 2010, 17 patients (median age, 80.0years) with histologically confirmed squamous cell carcinoma of the lip or oral cavity were treated by means of HDR brachytherapy using the mold technique after external beam radiotherapy (EBRT). Tumor sites included the buccal mucosa in eight cases, the gingiva in three cases, the lips in two cases, the floor of the mouth in two cases, and the hard palate in two cases. For all patients, EBRT (30Gy/15 fractions), was performed before HDR brachytherapy. Two 6-Gy fractions were delivered twice daily for 2days a week with an interval of 6hours between the fractions. The total HDR brachytherapy dose was 24Gy. Prior to EBRT, two patients with neck metastasis underwent neck dissection, and one patient with an exophytic tumor underwent tumor resection. Results: The median follow-up period was 53.4 (range, 4.8-83.4) months. Of the 17 patients, 14 (82.4%) achieved a complete response, and three (17.6%) displayed a partial response. Conclusions: Although there is a need to improve the technical aspects of the treatment protocol, HDR brachytherapy using the mold technique might be a therapeutic option for superficial lip or oral cavity tumors, especially in older patients who have a poor performance status or are in poor physical condition.

KW - Brachytherapy

KW - High-dose-rate

KW - Lip cancer

KW - Mold

KW - Oral cavity cancer

UR - http://www.scopus.com/inward/record.url?scp=84931274639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931274639&partnerID=8YFLogxK

U2 - 10.1186/s13014-015-0390-z

DO - 10.1186/s13014-015-0390-z

M3 - Article

C2 - 25888772

AN - SCOPUS:84931274639

VL - 10

JO - Radiation Oncology

JF - Radiation Oncology

SN - 1748-717X

IS - 1

M1 - 81

ER -